

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of mast cell activation (GO:0033005) | 6.57282226 |
| 2 | production of molecular mediator involved in inflammatory response (GO:0002532) | 6.23772307 |
| 3 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 6.17089961 |
| 4 | positive regulation of mast cell degranulation (GO:0043306) | 6.17089961 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.96442644 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.53816164 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.53816164 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.53816164 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.53816164 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.53816164 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 5.53816164 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.15371752 |
| 13 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 5.10334396 |
| 14 | regulation of mast cell degranulation (GO:0043304) | 5.09815863 |
| 15 | neutrophil mediated immunity (GO:0002446) | 5.09527132 |
| 16 | positive regulation of leukocyte degranulation (GO:0043302) | 4.93410603 |
| 17 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.78401591 |
| 18 | regulation of mast cell activation (GO:0033003) | 4.50548638 |
| 19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.42411089 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29479071 |
| 21 | detection of other organism (GO:0098543) | 4.23582227 |
| 22 | respiratory burst (GO:0045730) | 4.21317740 |
| 23 | leukocyte aggregation (GO:0070486) | 4.17066191 |
| 24 | cellular extravasation (GO:0045123) | 4.10130062 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07129658 |
| 26 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.06917997 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.03294678 |
| 28 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.01682376 |
| 29 | regulation of leukocyte degranulation (GO:0043300) | 3.97905037 |
| 30 | detection of bacterium (GO:0016045) | 3.97215794 |
| 31 | myeloid leukocyte mediated immunity (GO:0002444) | 3.95711903 |
| 32 | low-density lipoprotein particle clearance (GO:0034383) | 3.89023142 |
| 33 | response to peptidoglycan (GO:0032494) | 3.81476805 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.80516534 |
| 35 | response to host immune response (GO:0052572) | 3.80516534 |
| 36 | granulocyte activation (GO:0036230) | 3.78255394 |
| 37 | regulation of cholesterol storage (GO:0010885) | 3.69894401 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.66636213 |
| 39 | plasma lipoprotein particle clearance (GO:0034381) | 3.60974108 |
| 40 | response to host (GO:0075136) | 3.59368407 |
| 41 | response to host defenses (GO:0052200) | 3.59368407 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.59368407 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 3.59256606 |
| 44 | neutrophil activation (GO:0042119) | 3.59022287 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.41106686 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 3.40721135 |
| 47 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.34539612 |
| 48 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.34539612 |
| 49 | positive regulation of regulated secretory pathway (GO:1903307) | 3.31252592 |
| 50 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.25047799 |
| 51 | leukotriene metabolic process (GO:0006691) | 3.23866408 |
| 52 | regulation of regulated secretory pathway (GO:1903305) | 3.18678454 |
| 53 | leukocyte degranulation (GO:0043299) | 3.14043176 |
| 54 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11216686 |
| 55 | leukotriene biosynthetic process (GO:0019370) | 3.10805638 |
| 56 | plasma lipoprotein particle assembly (GO:0034377) | 3.06564157 |
| 57 | regulation of hypersensitivity (GO:0002883) | 3.04783021 |
| 58 | detection of external biotic stimulus (GO:0098581) | 3.04689015 |
| 59 | defense response to fungus (GO:0050832) | 3.04140996 |
| 60 | cytokine secretion (GO:0050663) | 3.03611819 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03398450 |
| 62 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.03335075 |
| 63 | negative regulation of cell killing (GO:0031342) | 3.03335075 |
| 64 | I-kappaB phosphorylation (GO:0007252) | 3.02420673 |
| 65 | pinocytosis (GO:0006907) | 2.99705808 |
| 66 | detection of biotic stimulus (GO:0009595) | 2.95138901 |
| 67 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.95113171 |
| 68 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.94896401 |
| 69 | natural killer cell mediated immunity (GO:0002228) | 2.94896401 |
| 70 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.94530877 |
| 71 | protein-lipid complex assembly (GO:0065005) | 2.94182786 |
| 72 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.92457461 |
| 73 | response to fungus (GO:0009620) | 2.92221519 |
| 74 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91133163 |
| 75 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.90339353 |
| 76 | protein carboxylation (GO:0018214) | 2.90339353 |
| 77 | leukocyte mediated cytotoxicity (GO:0001909) | 2.88435758 |
| 78 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.88076055 |
| 79 | positive regulation of hemostasis (GO:1900048) | 2.86576695 |
| 80 | positive regulation of blood coagulation (GO:0030194) | 2.86576695 |
| 81 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.85274509 |
| 82 | positive regulation of p38MAPK cascade (GO:1900745) | 2.84728961 |
| 83 | actin nucleation (GO:0045010) | 2.84080556 |
| 84 | microglial cell activation (GO:0001774) | 2.79509092 |
| 85 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.78152087 |
| 86 | positive regulation of coagulation (GO:0050820) | 2.75766924 |
| 87 | negative regulation of mast cell activation (GO:0033004) | 2.75214090 |
| 88 | macrophage activation (GO:0042116) | 2.73237153 |
| 89 | sequestering of metal ion (GO:0051238) | 2.73067275 |
| 90 | positive regulation of lipid storage (GO:0010884) | 2.71900066 |
| 91 | killing of cells of other organism (GO:0031640) | 2.69069932 |
| 92 | disruption of cells of other organism (GO:0044364) | 2.69069932 |
| 93 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.68372931 |
| 94 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65411600 |
| 95 | positive regulation of interferon-beta production (GO:0032728) | 2.64068326 |
| 96 | reactive oxygen species biosynthetic process (GO:1903409) | 2.63210049 |
| 97 | positive regulation of acute inflammatory response (GO:0002675) | 2.62854380 |
| 98 | lipoprotein transport (GO:0042953) | 2.62690363 |
| 99 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62536697 |
| 100 | regulation of phagocytosis (GO:0050764) | 2.60040234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.97756837 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52961252 |
| 3 | * BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.50612100 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.07434991 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.04164218 |
| 6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.01059022 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.75633353 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.45356105 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.40722223 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.36988941 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.90400362 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72326733 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.65048445 |
| 14 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.53906382 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43320372 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43138540 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31597667 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23658901 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.18529122 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11897626 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.11509358 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09369360 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.97859799 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96842254 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95072019 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93668777 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.92969273 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92958510 |
| 29 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.90789650 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89907336 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.87604051 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87114118 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87073033 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80621261 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.80204909 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79945086 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79289005 |
| 38 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73072590 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67986576 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66717584 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65915139 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64683820 |
| 43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63970384 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62311470 |
| 45 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.53699703 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.51701041 |
| 47 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49387602 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46212677 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41955975 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39326177 |
| 51 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38902637 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.33586886 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32609695 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31487116 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31463914 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30759171 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30696353 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29487518 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29120418 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27071088 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23627419 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22607274 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21176317 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.20622191 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18248911 |
| 66 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18242649 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15800104 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15422685 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13983667 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13138347 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12706869 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.09651512 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08322060 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07484594 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07481705 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06276935 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05881924 |
| 78 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05820265 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04334415 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01535714 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00514237 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97485997 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96164271 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95830390 |
| 85 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93898519 |
| 86 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92757044 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90866864 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90171021 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85474746 |
| 90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85215108 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84576654 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84396994 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84298161 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83794368 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83794368 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82830793 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82463523 |
| 98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79810466 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77475575 |
| 100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.74636020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.82250042 |
| 2 | MP0003436_decreased_susceptibility_to | 3.66170524 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.17236961 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 3.10742563 |
| 5 | MP0002419_abnormal_innate_immunity | 3.01133338 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.99964985 |
| 7 | MP0003724_increased_susceptibility_to | 2.95378580 |
| 8 | MP0009840_abnormal_foam_cell | 2.94147114 |
| 9 | MP0003303_peritoneal_inflammation | 2.76799302 |
| 10 | MP0009278_abnormal_bone_marrow | 2.73867742 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.60683728 |
| 12 | MP0009785_altered_susceptibility_to | 2.58865208 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.49629079 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.41612121 |
| 15 | MP0005025_abnormal_response_to | 2.34053717 |
| 16 | MP0006082_CNS_inflammation | 2.33140557 |
| 17 | MP0002139_abnormal_hepatobiliary_system | 2.30148074 |
| 18 | MP0001790_abnormal_immune_system | 2.20071936 |
| 19 | MP0005387_immune_system_phenotype | 2.20071936 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.11534533 |
| 21 | MP0000685_abnormal_immune_system | 2.11179344 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.05875501 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.04459166 |
| 24 | MP0000604_amyloidosis | 2.03672179 |
| 25 | MP0005360_urolithiasis | 2.01216875 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.00346420 |
| 27 | MP0001800_abnormal_humoral_immune | 1.99596168 |
| 28 | MP0002723_abnormal_immune_serum | 1.89912651 |
| 29 | MP0000343_altered_response_to | 1.86086738 |
| 30 | MP0001819_abnormal_immune_cell | 1.74978442 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.73721020 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.73354410 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.73341527 |
| 34 | MP0003690_abnormal_glial_cell | 1.69369730 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.68076469 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.66991362 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.64920633 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.64920633 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.63273167 |
| 40 | MP0004947_skin_inflammation | 1.60222392 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.60036312 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.59847610 |
| 43 | MP0003075_altered_response_to | 1.56870561 |
| 44 | MP0001958_emphysema | 1.54611476 |
| 45 | MP0005365_abnormal_bile_salt | 1.52724387 |
| 46 | MP0008469_abnormal_protein_level | 1.51440128 |
| 47 | MP0001853_heart_inflammation | 1.46583285 |
| 48 | MP0009764_decreased_sensitivity_to | 1.45817328 |
| 49 | MP0005083_abnormal_biliary_tract | 1.44755884 |
| 50 | MP0002405_respiratory_system_inflammati | 1.43991420 |
| 51 | MP0003448_altered_tumor_morphology | 1.43407464 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.40886628 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.39777139 |
| 54 | MP0005164_abnormal_response_to | 1.25096069 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.24811937 |
| 56 | MP0009763_increased_sensitivity_to | 1.20597445 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.20357831 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19791569 |
| 59 | MP0003252_abnormal_bile_duct | 1.19443209 |
| 60 | MP0002933_joint_inflammation | 1.17511202 |
| 61 | MP0000858_altered_metastatic_potential | 1.15908267 |
| 62 | MP0004510_myositis | 1.14384357 |
| 63 | MP0000716_abnormal_immune_system | 1.13055588 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.13010869 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.10918424 |
| 66 | MP0005166_decreased_susceptibility_to | 1.10217085 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.06885031 |
| 68 | MP0004883_abnormal_blood_vessel | 1.06095360 |
| 69 | MP0000609_abnormal_liver_physiology | 1.05081348 |
| 70 | MP0003279_aneurysm | 1.01964314 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.00016610 |
| 72 | MP0005408_hypopigmentation | 0.99835822 |
| 73 | MP0005023_abnormal_wound_healing | 0.98133135 |
| 74 | MP0002166_altered_tumor_susceptibility | 0.97063368 |
| 75 | MP0002398_abnormal_bone_marrow | 0.96763888 |
| 76 | MP0005390_skeleton_phenotype | 0.96590773 |
| 77 | MP0005451_abnormal_body_composition | 0.96472512 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 0.92284040 |
| 79 | MP0000767_abnormal_smooth_muscle | 0.92105014 |
| 80 | MP0002429_abnormal_blood_cell | 0.91478603 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.91160030 |
| 82 | MP0005671_abnormal_response_to | 0.89948077 |
| 83 | MP0001764_abnormal_homeostasis | 0.89564901 |
| 84 | MP0002722_abnormal_immune_system | 0.88240390 |
| 85 | MP0008260_abnormal_autophagy | 0.87684368 |
| 86 | MP0002254_reproductive_system_inflammat | 0.87642184 |
| 87 | MP0001243_abnormal_dermal_layer | 0.87010855 |
| 88 | MP0010155_abnormal_intestine_physiology | 0.85788506 |
| 89 | MP0001851_eye_inflammation | 0.85207548 |
| 90 | MP0005310_abnormal_salivary_gland | 0.84988547 |
| 91 | MP0000249_abnormal_blood_vessel | 0.81163729 |
| 92 | MP0004019_abnormal_vitamin_homeostasis | 0.80367152 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.79422787 |
| 94 | MP0005332_abnormal_amino_acid | 0.77660574 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.77619426 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.74742527 |
| 97 | MP0003195_calcinosis | 0.74328723 |
| 98 | MP0000371_diluted_coat_color | 0.69734956 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68892783 |
| 100 | MP0000598_abnormal_liver_morphology | 0.68869897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.61470663 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.37114452 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 5.40137488 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.34667563 |
| 5 | Spontaneous hematomas (HP:0007420) | 5.29213133 |
| 6 | Eczematoid dermatitis (HP:0000976) | 5.27039202 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 5.08900110 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.41275129 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.37970567 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.31497921 |
| 11 | Hematochezia (HP:0002573) | 4.22618592 |
| 12 | Joint hemorrhage (HP:0005261) | 3.88590169 |
| 13 | Glomerulonephritis (HP:0000099) | 3.86692417 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.77085471 |
| 15 | Gingival bleeding (HP:0000225) | 3.74772892 |
| 16 | Gingivitis (HP:0000230) | 3.60741052 |
| 17 | Deep venous thrombosis (HP:0002625) | 3.59104866 |
| 18 | Stomatitis (HP:0010280) | 3.58632023 |
| 19 | Recurrent skin infections (HP:0001581) | 3.55038654 |
| 20 | Obstructive lung disease (HP:0006536) | 3.50455104 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.50455104 |
| 22 | Urticaria (HP:0001025) | 3.40519816 |
| 23 | Conjunctival telangiectasia (HP:0000524) | 3.35926447 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.34899753 |
| 25 | Myositis (HP:0100614) | 3.34743110 |
| 26 | Prostate neoplasm (HP:0100787) | 3.27480005 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.26640229 |
| 28 | Complement deficiency (HP:0004431) | 3.24312415 |
| 29 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.20101224 |
| 30 | Axonal loss (HP:0003447) | 3.09339732 |
| 31 | Myocardial infarction (HP:0001658) | 2.98492466 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92337110 |
| 33 | Mucopolysacchariduria (HP:0008155) | 2.92337110 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.90736024 |
| 35 | Amyloidosis (HP:0011034) | 2.88430794 |
| 36 | Xanthomatosis (HP:0000991) | 2.83826407 |
| 37 | Abnormality of complement system (HP:0005339) | 2.83162591 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.82720797 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.82720797 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.82720797 |
| 41 | Loss of speech (HP:0002371) | 2.81177964 |
| 42 | Epistaxis (HP:0000421) | 2.80656534 |
| 43 | Periodontitis (HP:0000704) | 2.78615271 |
| 44 | Menorrhagia (HP:0000132) | 2.64996605 |
| 45 | Global brain atrophy (HP:0002283) | 2.64415898 |
| 46 | Pustule (HP:0200039) | 2.64044535 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.63940266 |
| 48 | Orchitis (HP:0100796) | 2.61380334 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61294720 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61294720 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61294720 |
| 52 | Nephritis (HP:0000123) | 2.51781194 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.51462380 |
| 54 | Esophageal varix (HP:0002040) | 2.50867527 |
| 55 | Cellulitis (HP:0100658) | 2.50852721 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.50112294 |
| 57 | Disinhibition (HP:0000734) | 2.47995011 |
| 58 | Pulmonary embolism (HP:0002204) | 2.47598346 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.43120191 |
| 60 | Hypercholesterolemia (HP:0003124) | 2.40963786 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.39891768 |
| 62 | Abnormal platelet volume (HP:0011876) | 2.34088540 |
| 63 | Thick nail (HP:0001805) | 2.28726167 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.26196778 |
| 65 | Vasculitis (HP:0002633) | 2.24262759 |
| 66 | Upper motor neuron abnormality (HP:0002127) | 2.21804266 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.19218934 |
| 68 | Pathologic fracture (HP:0002756) | 2.18935938 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.18797815 |
| 70 | Abnormal platelet function (HP:0011869) | 2.18797815 |
| 71 | Thoracic kyphosis (HP:0002942) | 2.17532282 |
| 72 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.16886715 |
| 73 | Prolonged partial thromboplastin time (HP:0003645) | 2.12433624 |
| 74 | Microcytic anemia (HP:0001935) | 2.10068251 |
| 75 | Polycythemia (HP:0001901) | 2.08931338 |
| 76 | Poor head control (HP:0002421) | 2.03208104 |
| 77 | Spondylolisthesis (HP:0003302) | 2.02408116 |
| 78 | Peripheral demyelination (HP:0011096) | 2.01799191 |
| 79 | Meningitis (HP:0001287) | 2.00262347 |
| 80 | Increased mean platelet volume (HP:0011877) | 1.99908540 |
| 81 | Cerebral hemorrhage (HP:0001342) | 1.99572291 |
| 82 | Retrobulbar optic neuritis (HP:0100654) | 1.98914921 |
| 83 | Optic neuritis (HP:0100653) | 1.98914921 |
| 84 | Petechiae (HP:0000967) | 1.98203611 |
| 85 | Osteomyelitis (HP:0002754) | 1.96626252 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96363450 |
| 87 | Osteolytic defects of the hand bones (HP:0009699) | 1.96363450 |
| 88 | Abnormality of the prostate (HP:0008775) | 1.96000272 |
| 89 | Bruising susceptibility (HP:0000978) | 1.94900249 |
| 90 | Vertebral compression fractures (HP:0002953) | 1.93847804 |
| 91 | Purpura (HP:0000979) | 1.93669709 |
| 92 | Leukocytosis (HP:0001974) | 1.92194832 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 1.90210811 |
| 94 | Hypophosphatemia (HP:0002148) | 1.87817272 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 1.87402102 |
| 96 | Inflammation of the large intestine (HP:0002037) | 1.86848678 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.85986908 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 1.85156420 |
| 99 | Hyperlipoproteinemia (HP:0010980) | 1.84799705 |
| 100 | Mucosal telangiectasiae (HP:0100579) | 1.82120138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.09697689 |
| 2 | RIPK4 | 3.96922296 |
| 3 | ERN1 | 3.54797247 |
| 4 | IRAK4 | 3.23939426 |
| 5 | KIT | 2.96876646 |
| 6 | CSK | 2.75056482 |
| 7 | FGR | 2.68653536 |
| 8 | MAP3K14 | 2.68436718 |
| 9 | TYK2 | 2.64387404 |
| 10 | IRAK3 | 2.52085811 |
| 11 | TEC | 2.50648513 |
| 12 | TBK1 | 2.32699224 |
| 13 | BTK | 1.90155430 |
| 14 | EPHB1 | 1.87697901 |
| 15 | RIPK1 | 1.86520544 |
| 16 | TAOK3 | 1.85066863 |
| 17 | ZAP70 | 1.76055893 |
| 18 | FES | 1.72958165 |
| 19 | ITK | 1.71033364 |
| 20 | MAP4K1 | 1.57151198 |
| 21 | TGFBR2 | 1.57099036 |
| 22 | HCK | 1.55767599 |
| 23 | JAK1 | 1.54832692 |
| 24 | CAMK1D | 1.54272652 |
| 25 | TRPM7 | 1.51975274 |
| 26 | IKBKE | 1.39392484 |
| 27 | TXK | 1.35861646 |
| 28 | STK10 | 1.32663403 |
| 29 | PTK2 | 1.26995356 |
| 30 | MAP2K3 | 1.26256655 |
| 31 | TRIB3 | 1.21563158 |
| 32 | SYK | 1.18740043 |
| 33 | PTK6 | 1.16971255 |
| 34 | TTN | 1.16617071 |
| 35 | LYN | 1.16482135 |
| 36 | DAPK2 | 1.14344520 |
| 37 | PIK3CG | 1.12063877 |
| 38 | MATK | 1.11114126 |
| 39 | JAK2 | 1.10348489 |
| 40 | IKBKB | 1.10183956 |
| 41 | SIK2 | 1.07604801 |
| 42 | YES1 | 1.04395076 |
| 43 | CDK9 | 1.04042575 |
| 44 | JAK3 | 0.99888989 |
| 45 | LCK | 0.99515846 |
| 46 | CSF1R | 0.99435014 |
| 47 | MAP3K13 | 0.97048756 |
| 48 | FYN | 0.91669703 |
| 49 | NEK9 | 0.91041578 |
| 50 | CAMK1G | 0.88052439 |
| 51 | RPS6KA4 | 0.82939487 |
| 52 | CDK6 | 0.78845854 |
| 53 | MAPK11 | 0.78328064 |
| 54 | BCKDK | 0.77433898 |
| 55 | EGFR | 0.74888685 |
| 56 | EIF2AK2 | 0.72300808 |
| 57 | PKN2 | 0.72080524 |
| 58 | NME2 | 0.72047467 |
| 59 | MAP3K7 | 0.71327186 |
| 60 | MST4 | 0.70302197 |
| 61 | MAPKAPK2 | 0.67803531 |
| 62 | BMX | 0.67505814 |
| 63 | LRRK2 | 0.66220803 |
| 64 | ABL1 | 0.66082174 |
| 65 | MST1R | 0.66043174 |
| 66 | IGF1R | 0.65123421 |
| 67 | KDR | 0.61850027 |
| 68 | FGFR4 | 0.61406994 |
| 69 | BMPR2 | 0.60868055 |
| 70 | ERBB3 | 0.60471984 |
| 71 | CLK1 | 0.59875692 |
| 72 | MAPK12 | 0.59067955 |
| 73 | PRKCD | 0.57805100 |
| 74 | SIK1 | 0.57002373 |
| 75 | MAP3K1 | 0.54161741 |
| 76 | PIM2 | 0.52359426 |
| 77 | GRK6 | 0.51357355 |
| 78 | MAP2K6 | 0.50863620 |
| 79 | DMPK | 0.50415893 |
| 80 | PAK4 | 0.49597817 |
| 81 | PRKCQ | 0.47656265 |
| 82 | PIM1 | 0.47017350 |
| 83 | CHUK | 0.46714467 |
| 84 | MOS | 0.46558306 |
| 85 | SCYL2 | 0.46422854 |
| 86 | TNK2 | 0.45108148 |
| 87 | STK24 | 0.45087055 |
| 88 | MAP3K11 | 0.43530640 |
| 89 | MAP3K6 | 0.42665077 |
| 90 | MAP3K10 | 0.41838225 |
| 91 | ABL2 | 0.41100422 |
| 92 | PRKG2 | 0.40723191 |
| 93 | MARK3 | 0.40395718 |
| 94 | CDK12 | 0.39667877 |
| 95 | CSNK1A1L | 0.38628805 |
| 96 | SRC | 0.34190707 |
| 97 | PDPK1 | 0.33778149 |
| 98 | CSNK1G1 | 0.32491656 |
| 99 | RPS6KA2 | 0.32249288 |
| 100 | CSNK1G3 | 0.31805605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.16658245 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.61682390 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60602661 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.58417922 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.51572357 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.48233333 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.39712195 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02700153 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96712467 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.94227869 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94008855 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89896242 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.87663825 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.80783535 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.72684636 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70348431 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.67155565 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64795711 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56554072 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48765596 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45990327 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.45900740 |
| 23 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.42580831 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37521253 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34671179 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30945922 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.28240000 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24314125 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24212990 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23397671 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20549062 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.17714240 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16500054 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12282940 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09858704 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09115464 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.08730914 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.07535904 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06367315 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.05312691 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02503395 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02313600 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01969459 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.01238081 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.01131276 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00210522 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98963621 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98774433 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97107676 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95432747 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93988053 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.93691863 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93469077 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86964421 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85390462 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83438865 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.82631527 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.79536668 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78926730 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78597914 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77510454 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.77357540 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77290184 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76423635 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73842458 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72496899 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.67648230 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66773148 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65261426 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.64725324 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62670873 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62413203 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57820973 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57799857 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.55793679 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53598219 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53433481 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52767813 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50930075 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50928475 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50543118 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50397779 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50251530 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48370606 |
| 85 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48349791 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48267703 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48180897 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46972787 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44202835 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40363892 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.40216927 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39928929 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36769462 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.34859023 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34853697 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.34431479 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.33510596 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33223509 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.32381855 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31799891 |

